FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047049301> ?p ?o ?g. }

• W2047049301 endingPage "142" @default.
• W2047049301 startingPage "136" @default.
• W2047049301 abstract "CKD‑602 (7‑[2‑(N‑isopropylamino) ethyl]‑(20S)‑camptothecin, belotecan) is a synthetic water‑soluble camptothecin derivative and topoisomerase I inhibitor that has been shown to exert a clinical anticancer effect on various types of tumor. In the present study, the anticancer effects of CKD‑602 on the following three human oral squamous cell carcinoma (OSCC) cell lines originating from Korean cancer patients: YD‑8 (tongue), YD‑9 (buccal mucosa) and YD‑38 (lower gingiva) were analyzed. The apoptotic proportion of the cells and cell cycle position were analyzed using flow cytometry. The expression of cell cycle regulatory proteins was detected by western blot analysis. CKD‑602 was demonstrated to exert a time‑ and dose‑dependent antiproliferative effect in all cell lines in vitro, however, susceptibility to CKD‑602 at 72 h following treatment varied among the three cell lines, with 50% inhibition of cell viability at concentrations of 2.4 µg/ml for YD‑8, 0.18 µg/ml for YD‑9 and 0.05 µg/ml for YD‑38. To investigate the underlying mechanism of the CKD‑602 antiproliferative effect, a cell cycle‑analysis was conducted in the three OSCC cell lines and CKD‑602 treatment was observed to induce G2/M phase arrest. Furthermore, western blot analysis revealed that the expression levels of phospho‑cdc2 (Tyr 15), cyclin A2 and cyclin B1 were increased in a time‑dependent manner, following the administration of CKD‑602. In the fluorescence‑activated cell sorting analysis, the number of apoptotic cells was also increased in a dose‑dependent manner following CKD‑602 treatment of the OSCC cell lines. The results suggest that CKD‑602 may inhibit the proliferation of OSCC oral cancer cells derived from samples from Korean patients by apoptosis and by G2/M phase arrest." @default.
• W2047049301 created "2016-06-24" @default.
• W2047049301 creator A5037752574 @default.
• W2047049301 creator A5057877443 @default.
• W2047049301 creator A5067222768 @default.
• W2047049301 date "2014-10-30" @default.
• W2047049301 modified "2023-09-28" @default.
• W2047049301 title "Anticancer effects of CKD-602 (Camtobell®) via G2/M phase arrest in oral squamous cell carcinoma cell lines" @default.
• W2047049301 cites W1831102019 @default.
• W2047049301 cites W2001887547 @default.
• W2047049301 cites W2005701686 @default.
• W2047049301 cites W2007305884 @default.
• W2047049301 cites W2011712090 @default.
• W2047049301 cites W2023576111 @default.
• W2047049301 cites W2027053077 @default.
• W2047049301 cites W2034281671 @default.
• W2047049301 cites W2035646330 @default.
• W2047049301 cites W2038143768 @default.
• W2047049301 cites W2039382131 @default.
• W2047049301 cites W2057940648 @default.
• W2047049301 cites W2059731771 @default.
• W2047049301 cites W2063486718 @default.
• W2047049301 cites W2068577449 @default.
• W2047049301 cites W2079340434 @default.
• W2047049301 cites W2080125477 @default.
• W2047049301 cites W2087198648 @default.
• W2047049301 cites W2092975253 @default.
• W2047049301 cites W2109408011 @default.
• W2047049301 cites W2116851038 @default.
• W2047049301 cites W2124624490 @default.
• W2047049301 cites W2127248987 @default.
• W2047049301 cites W2132600317 @default.
• W2047049301 cites W2155716214 @default.
• W2047049301 cites W2156114133 @default.
• W2047049301 cites W2158301508 @default.
• W2047049301 cites W2182506758 @default.
• W2047049301 doi "https://doi.org/10.3892/ol.2014.2648" @default.
• W2047049301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4246617" @default.
• W2047049301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25435947" @default.
• W2047049301 hasPublicationYear "2014" @default.
• W2047049301 type Work @default.
• W2047049301 sameAs 2047049301 @default.
• W2047049301 citedByCount "8" @default.
• W2047049301 countsByYear W20470493012016 @default.
• W2047049301 countsByYear W20470493012017 @default.
• W2047049301 countsByYear W20470493012018 @default.
• W2047049301 countsByYear W20470493012019 @default.
• W2047049301 crossrefType "journal-article" @default.
• W2047049301 hasAuthorship W2047049301A5037752574 @default.
• W2047049301 hasAuthorship W2047049301A5057877443 @default.
• W2047049301 hasAuthorship W2047049301A5067222768 @default.
• W2047049301 hasBestOaLocation W20470493011 @default.
• W2047049301 hasConcept C105696609 @default.
• W2047049301 hasConcept C120504264 @default.
• W2047049301 hasConcept C1491633281 @default.
• W2047049301 hasConcept C153911025 @default.
• W2047049301 hasConcept C185592680 @default.
• W2047049301 hasConcept C190283241 @default.
• W2047049301 hasConcept C199835354 @default.
• W2047049301 hasConcept C2778437423 @default.
• W2047049301 hasConcept C2779682216 @default.
• W2047049301 hasConcept C2781018059 @default.
• W2047049301 hasConcept C29537977 @default.
• W2047049301 hasConcept C502942594 @default.
• W2047049301 hasConcept C53227056 @default.
• W2047049301 hasConcept C54355233 @default.
• W2047049301 hasConcept C553184892 @default.
• W2047049301 hasConcept C55493867 @default.
• W2047049301 hasConcept C62112901 @default.
• W2047049301 hasConcept C71924100 @default.
• W2047049301 hasConcept C81885089 @default.
• W2047049301 hasConcept C86803240 @default.
• W2047049301 hasConceptScore W2047049301C105696609 @default.
• W2047049301 hasConceptScore W2047049301C120504264 @default.
• W2047049301 hasConceptScore W2047049301C1491633281 @default.
• W2047049301 hasConceptScore W2047049301C153911025 @default.
• W2047049301 hasConceptScore W2047049301C185592680 @default.
• W2047049301 hasConceptScore W2047049301C190283241 @default.
• W2047049301 hasConceptScore W2047049301C199835354 @default.
• W2047049301 hasConceptScore W2047049301C2778437423 @default.
• W2047049301 hasConceptScore W2047049301C2779682216 @default.
• W2047049301 hasConceptScore W2047049301C2781018059 @default.
• W2047049301 hasConceptScore W2047049301C29537977 @default.
• W2047049301 hasConceptScore W2047049301C502942594 @default.
• W2047049301 hasConceptScore W2047049301C53227056 @default.
• W2047049301 hasConceptScore W2047049301C54355233 @default.
• W2047049301 hasConceptScore W2047049301C553184892 @default.
• W2047049301 hasConceptScore W2047049301C55493867 @default.
• W2047049301 hasConceptScore W2047049301C62112901 @default.
• W2047049301 hasConceptScore W2047049301C71924100 @default.
• W2047049301 hasConceptScore W2047049301C81885089 @default.
• W2047049301 hasConceptScore W2047049301C86803240 @default.
• W2047049301 hasIssue "1" @default.
• W2047049301 hasLocation W20470493011 @default.
• W2047049301 hasLocation W20470493012 @default.
• W2047049301 hasLocation W20470493013 @default.
• W2047049301 hasLocation W20470493014 @default.
• W2047049301 hasOpenAccess W2047049301 @default.

• next